AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Signozid M 40mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Signova Pharma Pvt Ltd

Salt Composition

Gliclazide (40mg) + Metformin (500mg)

Overview Signozid M 40mg/500mg Tablet

Diabexe Duo 40mg/500mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This dual-action formula helps manage blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan that should incorporate a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a fast-acting sugar source (e.g., glucose tablets, juice) to counteract hypoglycemia, and maintain regular mealtimes. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Signozid M 40mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Signozid M 40mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Signozid M 40mg/500mg Tablet should be administered with a meal.

Common Side effects of Signozid M 40mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Signozid M 40mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Signozid M 40mg/500mg Tablet with a meal.

How Signozid M 40mg/500mg Tablet works:

Gliclazide and Metformin, combined at 40mg/500mg, are the active ingredients in Sinozid M tablets, a medication for managing diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Signozid M 40mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Signozid M 40mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is inadvisable. Exceptionally, a physician might prescribe it in critical circumstances where the potential advantages outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and the use of Sinozid M 40mg/500mg tablets are likely incompatible. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Signozid M 40mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Signozid M 40mg/500mg tablets. Physician consultation is necessary. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Signozid M 40mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, Signozid M 40mg/500mg tablets are unsuitable for individuals with severe hepatic dysfunction.

What if you forget to take Signozid M 40mg/500mg Tablet :

Should you forget a Signozid M 40mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Signozid M 40mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Signozid M 40mg/500mg Tablet

Signozid M 40mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's unsuitable for type 1 diabetes.
Signozid M 40mg/500mg Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Signozid M 40mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Signozid M 40mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in older adults, those with kidney problems, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Prolonged Signozid M 40mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Signozid M 40mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Signozid M 40mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Signozid M 40mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Signozid M 40mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Signozid M 40mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Signozid M 40mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged Signozid M 40mg/500mg Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Signozid M 40mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Signozid M 40mg/500mg Tablet and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Signozid M 40mg/500mg Tab...
60
MRP 70
14% off